Editas Medicine (EDIT) Leases: 2019-2025
Historic Leases for Editas Medicine (EDIT) over the last 7 years, with Sep 2025 value amounting to $17.6 million.
- Editas Medicine's Leases fell 50.79% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year decrease of 50.79%. This contributed to the annual value of $32.6 million for FY2024, which is 3.34% down from last year.
- Latest data reveals that Editas Medicine reported Leases of $17.6 million as of Q3 2025, which was down 7.51% from $19.0 million recorded in Q2 2025.
- Editas Medicine's 5-year Leases high stood at $43.6 million for Q4 2022, and its period low was $17.6 million during Q3 2025.
- Moreover, its 3-year median value for Leases was $32.6 million (2024), whereas its average is $30.6 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 68.45% in 2023, then plummeted by 50.79% in 2025.
- Quarterly analysis of 5 years shows Editas Medicine's Leases stood at $26.2 million in 2021, then skyrocketed by 66.77% to $43.6 million in 2022, then dropped by 22.84% to $33.7 million in 2023, then fell by 3.34% to $32.6 million in 2024, then tumbled by 50.79% to $17.6 million in 2025.
- Its Leases was $17.6 million in Q3 2025, compared to $19.0 million in Q2 2025 and $26.4 million in Q1 2025.